Hims and Hers Stock Is a Screaming Buy

This is more about aggravation than stock... This is more about aggravation than stock...                                                                                                      EAC Rerun to WD From 5/13/24 [Wealth Daily] Jeff Siegel / May 15, 2024 Hims and Hers Stock Is a Screaming Buy Last week, shares of Hims and Hers Health Inc. (NYSE: HIMS) fell 8% after the company’s CEO, Andrew Dudum, said he would be eager to hire anti-Israel protesters. [hims and hers stock] I’m not going to lie. If I were the CEO of a publicly traded company, I’d delete my Twitter account immediately. It just doesn’t seem worth it. It’s hard enough running a public company. Why would you want to add more stress to your life? BlackRock's Secret Bitcoin Play (NOT a Coin or ETF) World’s largest asset manager BlackRock recently launched its new Bitcoin ETF... But here’s the thing... BlackRock has quietly invested $400 million in a lesser-known Bitcoin play that’s gone unnoticed. This secret investment is accessible through an ordinary brokerage account, allowing you to start with around $25 today. [The full story can be found right here.]( But this is more about aggravation than stock valuations. Truth is, no matter what a CEO does or says, if the stock is solid, boycotts and bad press tend to have little effect over the long-haul. Aside from Anheuser-Busch (NYSE: BUD), which is still feeling the pain from a boycott against the company after it hired social media personality Dylan Mulvaney to promote the beer, I’ve never really seen a stock suffer, long-term, anyway, from these types of things. In fact, after Hims and Hers stock sold off last week, I told some folks to buy it. Those who listened made a quick buck. [hims and hers stock1] This was right before the company announced some fairly impressive earnings last week. Here are some highlights … - Revenue was $278.2 million for the first quarter of 2024 compared to $190.8 million for the first quarter of 2023, representing an increase of 46% year-over-year. - Gross margin was 82% for the first quarter of 2024 compared to 80% for the first quarter of 2023. - Net income was $11.1 million for the first quarter of 2024 compared to a net loss of $10.1 million for the first quarter of 2023. The company has plenty of cash, too. And with a nice tailwind that’ll likely push full year revenues up by around 25% for 2024. One American Firm's Top-Secret AI Tech Could Help Defeat Hamas One tiny American firm is working with the FBI, CIA, and NSA to develop advanced AI technology. It’s the most well-connected AI firm in the world... This firm’s technology has already disrupted Syrian air defenses, destroyed an Iranian uranium facility, and thwarted cyberattacks on U.S. power plants. Not to mention, Ukraine would not have made nearly as much progress repelling Russia’s invasion without this advanced AI tech. Now this tiny AI defense firm is set to turn the tides of the Israel-Hamas war... And hand its early investors as much as 10x their money. [Learn more about this small AI defense company before its stock soars.]( Hims and Hers Stock Will Deliver Say what you want about Andrew Dudum, but the bottom line is that there is very little chance that his recent controversial statements will have any sustaining effect on the long-term value of the company. As long as the market cooperates, Hims and Hers stock should be trading around $16.50 a share by December. That would be a potential 26% gain. Not bad for what is essentially a boner pill company. Of course, if you’re looking for more bang for your buck, consider [this new stimulus stipends program](. Some folks are actually using it to earn nearly $8,000 per quarter. Now I’m not going to lie: I’m no fan of government stimulus programs. But I’m also not a fan of turning away easy money. If the government is willing to hand over $8,000 per quarter, of course you’re going to take it. Which is why I’m including a link to [this report]( which shows you exactly how you can get some of this action for yourself, and [start claiming thousands of dollars in new government stimulus spending](. Indeed, I may be bullislh on boner pills, but I'm far more bullish on getting some of that stimulus money for myself. It's just easy money. To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]Check us out on YouTube!]( [[follow basic]@JeffSiegel on Twitter]( Jeff is the founder and managing editor of Green Chip Stocks. For more on Jeff, go to his editor's [page](. Want to hear more from Jeff? [Sign up to receive emails directly from him]( ranging from market commentaries to opportunities that he has his eye on. [Feedback? get in touch](mailto:/newsletter@wealthdaily.com?subject=Wealth%20Daily%20feedback) [Read this email online]( [Manage Newsletters]( [Share on Twitter]( You signed up for our newsletter with the email {EMAIL}. You can manage your subscription and get our privacy policy [here](. This email is from Angel Publishing, 3 East Read Street, Baltimore, MD 21202 © Wealth Daily.